ARCHIVES

GAO Report Finds Hydrazine Sulfate Trials Were Accurate

This article is from The Cancer Letter archive.

Vol. 21 No. 37 | September 29, 1995

Download PDF Visit The Full Archive

Related Articles

Bristol-Myers Adds UCLA, Fox Chase To Grants Program

April 12, 1985

In Brief: Hellman To Head DCT board; Gard Joins Colorado Group; NCI May Support Death Index

September 12, 1980

Oncologists Tell Congress Community Cancer Practices Are Not Adequately Reimbursed

April 4, 2014

The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year

April 20, 2012

Clinical Trials Approved By NCI Last Month

March 29, 2002

In Brief: Move To NCI director’s Office gives Greater Visibility To NCI Liaison Office

September 13, 1996